CLINICAL_TRIALS
trial_result
· 2023-04-14
Clinical Trial Update: Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis [Phase 2]
Summary
Phase 2 trial of once-weekly oral aminopterin for moderate-to-severe psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Syntrix Biosystems, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-14